Move over glucometer, there’s new tech in town revolutionizing glucose measurement. The continuous glucose monitor (CGM) measures a person’s blood glucose profile every 1 to 5 minutes—a dramatic upgrade over the glucometer’s isolated snapshots. CGM’s game-changing technology will increasingly inform treatment decisions for those living with diabetes and prediabetes as well as those who care for them. This activity will feature real-world cases to increase your knowledge of CGM data and how it can help you improve patient outcomes.
At the completion of this knowledge-based activity, participants will be able to:
- Explain the clinical evidence and influence of continuous glucose monitoring (CGM) on diabetes outcomes.
- Compare and contrast CGM devices.
- Discuss the role a pharmacist can play in enhancing diabetes care using CGM.;
- Interpret the data from a CGM, including the ambulatory glucose profile, time in range, and trends in glucose levels depicted by real-time arrows.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-015-H01-P
To obtain credit for Advances in Diabetes Technology- Part 1: A Monitoring Revolution, participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.Initial release date: March 14, 2021
Expiration date: March 14, 2024 - No credit granted after this date
Development and Support
Advances in Diabetes Technology- Part 1: A Monitoring Revolution is an activity for pharmacists developed by the American Pharmacists Association. This activity is supported by an independent educational grant from Abbott Diabetes Care, Inc. © 2021 American Pharmacists Association
Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2021 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-015-H01-P||0.15 CEUs||March 14, 2021 - March 14, 2024|